Merck
& Co., Inc.
Merck
Research Laboratories
Senior Director, Strategic Research Initiatives
As
a Senior Director within Merck’s External Scientific Affairs department, Dr.
Newbold is responsible for leading a team of scientists in the evaluation and
negotiation of relationships in broad areas of platform technologies, covering
the disciplines of chemistry and biology, automation and instrumentation
investment, and the area of molecular profiling which includes both genomics and
proteomics technologies. He and his
group have executed over 65 agreements in the past 5 years, helping to advance
Merck’s drug discovery capabilities with external partnerships in the academic
and biotechnology communities.
Prior to Merck, Dr. Newbold held a postdoctoral fellowship with Nobel Laureate E.J. Corey at Harvard University, following doctoral studies in synthetic organic chemistry at the University of Rochester. He received his undergraduate training in chemistry at Union College.
Merck & Co.,
Inc.
is a leading research-driven pharmaceutical products and services company. Merck
discovers, develops, manufactures and markets a broad range of innovative
products to improve human and animal health, directly and through its joint
ventures.